Lloyd Minor
At a glance: Lloyd Minor is Director at Biogen (BIIB). Their latest SEC Form 4, filed Aug 5, 2026, reported a sale of $121K. On file: 0 purchase lines ($0) and 2 sale lines ($240K).
Disclosed holdings: about $671K of BIIB stock: 2,689 shares reported on their latest Form 4 (filed Aug 5, 2026), valued at the Nov 20, 2026 close of $249.69. This counts only BIIB shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Biogen Inc. (BIIB)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Lloyd Minor's InsiderPrint
2 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
- Bump outward: a purchase (0)
- Dent inward: a sale (2)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 5SEC | BIIBBiogen Inc. | Sell Plan | 5933,282 held (−15%) | $203.34 | $121K | +22.8% |
| Aug 5SEC | BIIBBiogen Inc. | Sell Plan | 5932,689 held (−18%) | $200.96 | $119K | +24.2% |
- Sell
Director Lloyd Minor sold $121K of BIIB at $203.34 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Lloyd Minor sold $119K of BIIB at $200.96 — pre-scheduled 10b5-1 plan sale.
Follow Lloyd Minor
Get one email when Lloyd Minor files a new purchase or sale. Free.
At most one email a day about Lloyd Minor, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.